Explorer Investments Acquires 60% Stake in Biogerm, Strengthening Commitment to Innovation and Growth in Microbiological and Chemical Analysis Sector.
Lisbon, Portugal – Explorer Investments has announced the acquisition of a 60% stake in Biogerm, S.A., a market leader in microbiological and chemical analysis, with a strong focus on public health, including food, water, air, environment, and soil testing.
Explorer Investments continues its strategy of consolidating market leaders, partnering with Biogerm to accelerate its growth, expand its presence in the Iberian market, and enhance its operational capabilities. This transaction marks the eighth acquisition by the Explorer IV Fund, which includes well-known companies such as the Your Group and Gosimac.
Biogerm: A Legacy of Tradition and Innovation
Founded 30 years ago by António Araújo and Mavildia Rufino, Biogerm initially focused on developing the Lowenstein culture medium for tuberculosis bacillus research. Since then, the company has rapidly expanded its operations, offering a wide range of analysis services and solidifying its leadership in the public health sector.
With over 50 employees and a client base of more than 2,000, Biogerm is renowned for providing high-quality, integrated solutions to mitigate contamination risks and ensure safety across various environments.
Commitment to Growth and Innovation
With the acquisition of a 60% stake in Biogerm, Explorer Investments reinforces its commitment to supporting businesses with high growth potential. The company is now poised to expand its capacity, including plans for a new laboratory that will triple its response capacity. This will enable Biogerm to continue delivering high-value-added services while maintaining the consistency and quality that defines its brand.
The investment also aligns with Explorer Investments’ strategy to support technological advancements and foster expansion, with future plans to acquire additional companies in the sector.
Pedro Coutinho, Partner at Explorer Investments, stated, “This acquisition is a key step in enhancing Biogerm’s market presence. We are excited to work alongside the founding shareholders to ensure continuity in management and create the necessary conditions for solid and sustainable growth.”
Diamantino Ribeiro, CEO of Biogerm, added, “The involvement of Explorer Investments represents a unique opportunity to create a new dynamic for Biogerm, enabling the company to reach a new level of growth and innovation in the public health sector in Portugal.”
A Strong Future Ahead
This partnership is expected to not only foster the professionalisation of management teams but also expand Biogerm’s laboratory capabilities, offering broader services and reinforcing its market position.
